Follow

Crossing the Valley of Death

"In this Review, we quantify the discoveries that have been translated into approved therapies. While acknowledging the decades-long lag time between target identification and regulatory approval of derived therapeutics, we reasoned that addressing this question now is both legitimate and essential to guide future investments in the field."

nature.com/articles/s41586-023

Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.